Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Galectin Therapeutics Inc

Current price
2 USD +0.03 USD (+1.52%)
Last closed 1.95 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 131 119 240 USD
Yield for 12 month +63.93 %
21.11.2021 - 28.11.2021

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia. Address: 4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071


WallStreet Target Price

11 USD

P/E ratio

Dividend Yield

3.3 %

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures GALT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Operating Margin TTM
PE Ratio
Return On Assets TTM -122.09 %
PEG Ratio
Return On Equity TTM -3727.95 %
Wall Street Target Price 11 USD
Revenue TTM
Book Value -0.86 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield 3.3 %
Gross Profit TTM
Earnings Share -0.76 USD
Diluted Eps TTM -0.76 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GALT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GALT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 3.3 %
Last Split Factor 1:6
Payout Ratio
Last Split Date 23.03.2012
Dividend Date

Stock Valuation GALT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.4121
Price Book MRQ 207.6975

Financials GALT

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators GALT

For 52 weeks

1.02 USD 2.47 USD
50 Day MA 1.99 USD
Shares Short Prior Month 1 879 676
200 Day MA 1.78 USD
Short Ratio 31.21
Shares Short 1 954 092
Short Percent 5.09 %